1. Home
  2. LPLA vs IMTXW Comparison

LPLA vs IMTXW Comparison

Compare LPLA & IMTXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPLA
  • IMTXW
  • Stock Information
  • Founded
  • LPLA 1989
  • IMTXW N/A
  • Country
  • LPLA United States
  • IMTXW Germany
  • Employees
  • LPLA N/A
  • IMTXW 343
  • Industry
  • LPLA Investment Bankers/Brokers/Service
  • IMTXW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LPLA Finance
  • IMTXW Health Care
  • Exchange
  • LPLA Nasdaq
  • IMTXW Nasdaq
  • Market Cap
  • LPLA N/A
  • IMTXW N/A
  • IPO Year
  • LPLA 2010
  • IMTXW N/A
  • Fundamental
  • Price
  • LPLA $227.00
  • IMTXW $3.43
  • Analyst Decision
  • LPLA Buy
  • IMTXW
  • Analyst Count
  • LPLA 12
  • IMTXW 0
  • Target Price
  • LPLA $287.27
  • IMTXW N/A
  • AVG Volume (30 Days)
  • LPLA 1.3M
  • IMTXW N/A
  • Earning Date
  • LPLA 07-25-2024
  • IMTXW N/A
  • Dividend Yield
  • LPLA 0.52%
  • IMTXW N/A
  • EPS Growth
  • LPLA 2.00
  • IMTXW N/A
  • EPS
  • LPLA 13.26
  • IMTXW N/A
  • Revenue
  • LPLA $10,467,609,000.00
  • IMTXW N/A
  • Revenue This Year
  • LPLA $18.97
  • IMTXW N/A
  • Revenue Next Year
  • LPLA $15.62
  • IMTXW N/A
  • P/E Ratio
  • LPLA $17.36
  • IMTXW N/A
  • Revenue Growth
  • LPLA 16.92
  • IMTXW N/A
  • 52 Week Low
  • LPLA $200.18
  • IMTXW N/A
  • 52 Week High
  • LPLA $289.88
  • IMTXW N/A
  • Technical
  • Relative Strength Index (RSI)
  • LPLA 29.97
  • IMTXW N/A
  • Support Level
  • LPLA $202.34
  • IMTXW N/A
  • Resistance Level
  • LPLA $284.59
  • IMTXW N/A
  • Average True Range (ATR)
  • LPLA 10.99
  • IMTXW 0.00
  • MACD
  • LPLA -4.72
  • IMTXW 0.00
  • Stochastic Oscillator
  • LPLA 31.95
  • IMTXW 0.00

About IMTXW Immatics N.V.

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Share on Social Networks: